Department of Clinical Virology, Heidelberg University, Baden-wurttemberg, Germany
Brief Report
Personalized Anti-HCMV Therapy: A Potential Addition to First-Line and Second-Line Therapies for HCMV-Positive Ovarian Tumors
Author(s): Resse Rass*
DOI:
10.37421/2736-657X.2023.7.172
Virology: Current Research received 187 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 